24500 Federal Register / Vol. 61, No. 95 / Wednesday, May 15, 1996 / Notices

development and maintenance of

performance measurements and

reporting under the plan. The Division

coordinates these activities with other

offices with implementation

responsibilities and functions related to

the Government Performance and

Results Act. The Division manages the

establishment of schedules and

procedures to ensure the availability of

supporting information. The Division

also develops functional requirements

for departmental policy support systems

in the legislative and strategic planning

areas; coordinates the planning of

evaluation and social research agenda

across the Department and coordinates

the regulatory review process within the

OASPE. Finally, the Division

coordinates and conducts policy

analysis in subjects and areas not

covered by, or cutting across, the

programmatic offices of the OASPE. In

collaboration with the Assistant

Secretary for Management and Budget,

conducts policy reviews related to the

Department’s Continuous Improvement

Program.

2. The Division of Data Policy serves

as the HHS focal point for data policy

analysis, planning and development, as

well as for coordination of data and

statistical policy within HHS. The

Division provides an Executive

Secretary, as well as leadership and staff

support, to the HHS Data Council, the

principal internal forum and advisory

body to the Secretary on data policy

issues, including data strategy, data

standards, and privacy issues. The

Division also provides direction and

oversight and serves as the HHS

Executive Director to the National

Committee on Vital and Health

Statistics, the statutory pubic advisory

body to the Secretary on health data and

statistics, and serves as the focal point

within HHS for all matters relating to

the Committee. The Division also

provides staff support to the ASPE and

OS leadership on a variety of

Departmentwide data policy issues and

initiatives, including statistical policy,

privacy, data standards, and data

planning issues, as well as data issues

in support of performance measurement

and performance partnership grants,

and directs a portfolio of developmental

projects in those areas. The Division

also maintains liaison with other

agencies and organizations on a variety

of data and statistical policy issues.

3. The Division of State and Local

Initiatives assists State, local and Tribal

governments, as well as communitybased programs, in developing,

implementing and evaluating innovative

approaches to improving programs and

systems which cut across the

programmatic offices of the ASPE. The

Division coordinates with the

Department’s OPDIVS and STAFFDIVS

to provide technical assistance. The

Division also coordinates with other

Federal Departments and agencies to

identify opportunities to improve

linkages, develop collaborative efforts,

and/or to establish partnerships to

improve the overall effectiveness of

federally funded programs. The Division

provides analytic support as well as

policy guidance to Departmental

OPDIVS and STAFFDIVS to improve

services delivered by community-based

organizations as well as State and local

governments for crosscutting program

areas. The Division collaborates with

State and local governments, in

cooperation with the Office of

Intergovernmental Affairs, to develop

mutually acceptable goals, objectives,

and performance measures for achieving

effective outcomes measures.

4. The Division of Modeling,

Computer and Technical Systems is

responsible for providing statistical,

scientific programming, modeling,

computer systems and other technical

staff services to policy analyses,

research and evaluation activities of the

OASPE. It coordinates on departmental

issues concerning income and poverty

with the Bureau of the Census and

annually revises and publishes the

Poverty Income Guidelines. Finally, it

provides technical assistance and advice

to other policy offices within the

Department on certain statistical and

specialized scientific policy analyses,

and administers a policy information

center for identifying and retrieving

evaluative and policy research studies.

Dated: May 8, 1996.

John J. Callahan,

Assistant Secretary for Management and

Budget.

[FR Doc. 96–12068 Filed 5–14–96; 8:45 am]

BILLING CODE 4110–12–M

Agency for Health Care Policy and

Research

Notice of Health Care Policy and

Research; Special Emphasis Panel

Meeting

In accordance with section 10(a) of

the Federal Advisory Committee Act (5

U.S.C., Appendix 2) announcement is

made of the following special emphasis

panel scheduled to meet during the

month of June 1996:

Name: Health Care Policy and Research

Special Emphasis Panel.

Date and Time: June 5, 1996, 11:30 a.m.

Place: Agency for Health Care Policy and

Research, 2101 E. Jefferson Street, Suite 400,

Rockville, MD 20852.

Open June 5, 1996, 11:30 a.m. to 11:45 a.m.

Closed for remainder of meeting.

Purpose: This Panel is charged with

conducting the initial review of grant

applications proposing conferences on issues

relevant to health services research.

Agenda: The open session of the meeting

on June 5, from 11:30 a.m. to 11:45 a.m., will

be devoted to a business meeting covering

administrative matters. During the closed

session, the committee will be reviewing and

discussing grant applications dealing with

health services research issues. In accordance

with the Federal Advisory Committee Act,

section 10(d) of 5 U.S.C., Appendix 2 and 5

U.S.C., 552b(c)(6), the Administrator,

AHCPR, has made a formal determination

that this latter session will be closed because

the discussions are likely to reveal personal

information concerning individuals

associated with the grant applications. This

information is exempt from mandatory

disclosure.

Anyone wishing to obtain a roster of

members or other relevant information

should contact Linda Blankenbaker,

Agency for Health Care Policy and

Research, Suite 400, 2101 East Jefferson

Street, Rockville, Maryland 20852,

Telephone (301) 594–1438.

Agenda items for this meeting are

subject to change as priorities dictate.

Dated: May 6, 1996.

Clifton R. Gaus,

Administrator.

[FR Doc. 96–12207 Filed 5–14–96; 8:45 am]

BILLING CODE 4160–90–M

Food and Drug Administration

[Docket No. 95N–0013]

Benton County Ag Center, Inc.;

Withdrawal of a Notice of Opportunity

for Hearing Proposing To Withdraw

Approval of Medicated Feed

Applications

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Center for Veterinary

Medicine (CVM), Food and Drug

Administration (FDA), is withdrawing a

notice of opportunity for hearing

(NOOH) on a proposal to withdraw

approval of 11 medicated feed

applications (MFA’s) held by Benton

County Ag Center, Inc. CVM has

determined that the firm is in

compliance with current good

manufacturing practice (CGMP)

regulations for medicated animal feeds

and has instituted a system to maintain

its compliance status.

EFFECTIVE DATE: May 15, 1996.
Federal Register / Vol. 61, No. 95 / Wednesday, May 15, 1996 / Notices 24501

FOR FURTHER INFORMATION CONTACT:

Karen A. Kandra, Center for Veterinary

Medicine (HFV–246), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1765.

SUPPLEMENTARY INFORMATION: In a notice

published in the Federal Register of

April 26, 1995 (60 FR 20497), CVM

provided an opportunity for hearing on

a proposal to withdraw approval of 11

MFA’s held by Benton County Ag

Center, Inc., for the manufacture of

animal feeds bearing or containing new

animal drugs. CVM took this action

based on the firm’s apparent failure to

comply with agency CGMP

requirements for medicated animal

feeds as evidenced by inspections

conducted on December 22, 1992, and

May 3, 4, 10, and 11, 1994.

In a letter that FDA received on May

23, 1995, in response to the notice,

Benton County Ag Center, Inc., stated it

had made the necessary corrections to

bring its operations into compliance

with CGMP requirements since the last

inspection. The letter requested that

FDA reinspect the feed mill to verify its

compliance status, and to withdraw the

NOOH.

On July 17 through 19, 1995, the Iowa

Department of Agriculture, under

contract with FDA pursuant to section

702(a) of the Federal Food, Drug, and

Cosmetic Act (the act) (21 U.S.C.

372(a)), reinspected the feed mill and

found that the firm had corrected the

previously noted CGMP deficiencies

that had formed the basis for the NOOH.

Additionally, FDA believes that the firm

has taken measures to ensure that it will

remain in compliance with CGMP’s.

Accordingly, CVM is withdrawing the

April 26, 1995, NOOH on the proposal

to withdraw approval of the firm’s

MFA’s.

This notice is issued under the

Federal Food, Drug, and Cosmetic Act

(sec. 512 (21 U.S.C. 360b)) and under

authority delegated to the Director,

Center for Veterinary Medicine (21 CFR

5.84).

Dated: April 2, 1996.

Michael J. Blackwell,

Deputy Director, Center for Veterinary

Medicine.

[FR Doc. 96–12155 Filed 5–14–96; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 91F–0424]

Witco Corp.; Withdrawal of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

withdrawal, without prejudice to a

future filing, of a food additive petition

(FAP 1B4282) proposing that the food

additive regulations be amended to

provide for the safe use of imidazolium

compounds, 2-(C17 and C17 unsaturated

alkyl)-1-[2-(C18 and C18 unsaturated

amido)ethyl]-4,5-dihydro-1-methyl,

methyl sulfates as a debonding agent in

paper products intended to contact

food.

FOR FURTHER INFORMATION CONTACT: Vir

D. Anand, Center for Food Safety and

Applied Nutrition (HFS–216), Food and

Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3081.

SUPPLEMENTARY INFORMATION: In a notice

published in the Federal Register of

November 29, 1991 (56 FR 61022), FDA

announced that a food additive petition

(1B4282) had been filed on behalf of

Sherex Chemical Co., Inc., P.O. Box

6464, Dublin, OH 43017 (currently

Witco Corp., Frantz Rd., P.O. Box 646,

Dublin, OH 43017). The petition

proposed to amend the food additive

regulations to provide for the safe use of

imidazolium compounds, 2-(C17 and

C17unsaturated alkyl)-1-[2-(C18 and C18

unsaturated amido)ethyl]-4,5-dihydro-1-

methyl, methyl sulfates as a wet

strength agent in paper products

intended to contact food. Subsequently,

upon a request from the petitioner, FDA

published an amended notice in the

Federal Register of April 15, 1992 (57

FR 13104), stating that the additive is

intended for use as a debonding agent

rather than as a wet strength agent as

indicated in the previous filing notice.

Witco Corp. has now withdrawn the

petition without prejudice to a future

filing (21 CFR 171.7).

Dated: April 30, 1996.

Alan M. Rulis,

Director, Office of Premarket Approval,

Center for Food Safety and Applied Nutrition.

[FR Doc. 96–12206 Filed 5–14–96; 8:45 am]

BILLING CODE 4160–01–F

Health Care Financing Administration

[HCFA R–0107]

Submitted for Collection of Public

Comment: Submission for OMB

Review

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, has submitted to the

Office of Management and Budget

(OMB) the following proposals for the

collection of information. Interested

persons are invited to send comments

regarding this burden estimate or any

other aspect of this collection of

information, including any of the

following subjects: (1) The necessity and

utility of the proposed information

collection for the proper performance of

the agency’s functions; (2) the accuracy

of the estimated burden; (3) ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) the use of automated collection

techniques or other forms of information

technology to minimize the information

collection burden.

1. Type of Request: Extension of a

currently approved collection; Title of

Information Collection: Medicaid—

Determining Liability of Third Parties;

Form No.: HCFA–R–0107; Use: The

information collected from Medicaid

applicants and recipients as well as

from State and local agencies is

necessary to determine the legal liability

of third parties to pay for medical

services in lieu of Medicaid payment;

Frequency: On occasion; Affected

Public: Federal Government and State,

local, or tribal government; Number of

Respondents: Varies; Total Annual

Responses: Varies; Total Annual Hours:

171,165.

To request copies of the proposed

paperwork collection referenced above,

E-mail your request, including your

address, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections should be sent

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Financial and Human

Resources, Management Planning and

Analysis Staff, Attention: Linda

Mansfield, Room C2–26–17, 7500

Security Boulevard, Baltimore,

Maryland 21244–1850.

Date: May 8, 1996.

Kathleen B. Larson,

Director, Management Planning and Analysis

Staff, Office of Financial and Human

Resources, Health Care Financing

Administration.

[FR Doc. 96–12106 Filed 5–14–96; 8:45 am]

BILLING CODE 4120–03–P

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration.

In compliance with the Paperwork

Reduction Act of 1995 (44 U.S.C. 3501

et seq.), the Health Care Financing